Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout. [Phase 1]

View source ↗

Summary

It describes a Phase Ib trial of peguricase in combination with methotrexate for uncontrolled gout, with recruitment ongoing. The study is sponsored by Shanghai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)
  • Peguricase (pegloticase)

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: Gout | Phase 1 | Status: RECRUITING